Claudia Rinciog, MSc
Claudia is a Health Economics Manager. Since joining Symmetron in 2013, she specialises in evidence review and economic modelling in many disease areas including bipolar disease, rheumatoid arthritis, obesity, oncology, Parkinson’s disease, cardiovascular and pulmonary disease. She has supported submissions to reimbursement authorities in Europe and North America, and developed poster presentations for international conferences and manuscripts for peer-reviewed publications. Claudia graduated summa cum laude from Lafayette College in Easton, Pennsylvania, with a double degree in Biochemistry (BSc) and Economics (BA). As part of her senior year Economics thesis, she performed a regression analysis on the impact of household HIV status on the economic well-being of households in Zambia. After graduation, Claudia pursued an MSc in International Health Policy and Health Economics at London School of Economics and Political Science (LSE). As part of her LSE dissertation, Claudia interned at Medtronic in Tolochenaz, Switzerland, where she performed an explanatory statistical analysis of aortic valve replacement hospital episodes in the NHS from 2000 to 2010.
Rinciog C, Sawyer L, Diamantopoulos A, et al. Costeffectiveness of an insertable cardiac monitor in a high-risk population in the UK. Open Heart 2019;6:e001037
Rinciog C, Sawyer L, Diamantopoulos A, Elkind M, Reynolds M, Tsintzos S, Ziegler PD, Quiroz M, Wolff C, Witte KK. Economic evaluation of insertable cardiac monitors to detect atrial fibrillation and subsequently moderate stroke risk in a high-risk population in the UK. ISPOR Europe 2018. Barcelona, Spain. November, 2018
Diamantopoulos A, Rinciog C, Forsey J, Glencorse M, Rizzo E, Murphy J. Vagus nerve stimulation for treatment-resistant depression: a budget impact analysis in England. ISPOR Europe 2018. Barcelona, Spain. November, 2018
Rinciog C, Bermingham S, Cornic L, Diamantopoulos A, Fan Y. Cost-effectiveness of nintedanib in idiopathic pulmonary fibrosis in the US. AMCP NEXUS 2018. October 22-25, 2018
KK. Witte, MSV. Elkind, M. Reynolds, SI. Tsintzos, PD. Ziegler, ME. Quiroz, C. Wolff, C. Rinciog, L. Sawyer, A. Diamantopoulos. Economic evaluation of insertable cardiac monitors in detecting previously undiagnosed atrial fibrillation and subsequently moderating stroke risk in a high-risk population in the UK. ESC Congress, 25-29 August 2018, Munich, Germany.
Rinciog C, Watkins M, Chang S, Maher TM, LeReun C, Esser D, Diamantopoulos A. A Cost-Effectiveness Analysis of Nintedanib in Idiopathic Pulmonary Fibrosis in the UK. 2017 Apr;35(4):479-491. doi: 10.1007/s40273-016-0480-2.
Rinciog C, Watkins M, Chang S, Maher T, LeReun C, Esser D, Diamantopoulos A. Nintedanib cost-effectiveness in idiopathic pulmonary fibrosis in the UK. PharmacoEconomics, published online: 31 December 2016
Tritaki G, Souliotis K, Bouros D, Papageorgiou I, Diamantopoulos A, Rinciog C, Schmidt U. Pharmacoeconomic assessment of nintedanib for the treatment of idiopathic pulmonary fibrosis in the Greek healthcare system. ISPOR 19th Annual European Congress. Vienna, Austria. October, 2016
Sawyer L, Azorin JM, Chang S, Rinciog C, Guiraud-Diawara A, Marre C, et al. Cost-effectiveness of asenapine in the treatment of bipolar I disorder patients with mixed episodes. J Med Econ 2014 Jul;17(7):508-19.
Rinciog C, Myrén KJ, Aldén M, Diamantopoulos A, LeReun C. An Indirect Treatment Comparison of Cabozantinib Verse Vandetanib in Progressive Medullary Thyroid Cancer (MTC). Value Health. 2014 Nov;17(7):A616-7. doi: 10.1016/j.jval.2014.08.2173. Epub 2014 Oct 26.
Azorin JM, Sawyer L, Chang S, Rinciog C, Guiraud-Diawara A, Marre C, et al. Cost-Effectiveness of Asenapine in the Treatment of Bipolar Disorder I Patients with Mixed Episodes. Value in Health. 2013;16(7):A549.
Mylon SE, Rinciog CI, Schmidt N, Gutierrez L, Wong GC, Nguyen TH. Influence of salts and natural organic matter on the stability of bacteriophage MS2. 2010 Jan 19;26(2):1035-42. doi: 10.1021/la902290t.
Buettner KM, Rinciog CI, Mylon SE. Aggregation kinetics of cerium oxide nanoparticles in monovalent and divalent electrolytes. Colloids and Surfaces A: Physicochemical and Engineering Aspects. Volume 366, Issues 1–3, 20 August 2010, Pages 74-79